Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
An easy reference to world market indices names, with notes on regional coverage and how to recognize key benchmarks in discussions.
28,329 articlesPfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
SoFi Technologies jumps after unveiling SoFiUSD, a bank-issued stablecoin with Mastercard settlement integration, fue...
AMD faces a high-stakes test as the AI buildout accelerates and competition intensifies. History warns advanced micro...
Markets that did not ride the pandemic rush are delivering resilience as higher rates persist. New data show how the ...
The CFPB signals that immigration status could influence a borrower's ability to repay a loan, potentially reshaping ...
As WWDC 2026 opens, Apple faces a pivotal moment: Tim Cook's leadership transition and a bold AI strategy that could ...
Netflix has staged a comeback that rewards patient investors, but the last year also exposed two distinct paths for t...
Oracle beat on earnings and grew its contract backlog to a record level, yet investors pounced on higher AI costs, se...
A wave of vault-based yield services blends familiar banking interfaces with hidden DeFi vaults, reshaping access to ...
Tensions abroad sparked fears of a jet fuel shortage, but industry data and regulators say the fuel crisis never exis...
Vanguard’s 2026 retirement snapshot reveals a paradox: record average balances mask a steep median gap, underscoring ...
Fox is weighing a bold $23 billion plan to buy Roku and seize control of the TV operating system. If completed, the d...